| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.44▲ | 1.44▲ | 1.45▲ | 1.48▲ | 1.75▼ |
| MA10 | 1.46▲ | 1.48▲ | 1.48▲ | 1.58▼ | 1.83▼ |
| MA20 | 1.48▲ | 1.48▲ | 1.52▼ | 1.81▼ | 2.20▼ |
| MA50 | 1.62▼ | 1.72▼ | 1.77▼ | 1.86▼ | 5.85▼ |
| MA100 | 1.81▼ | 1.95▼ | 1.93▼ | 3.64▼ | 24.80▼ |
| MA200 | 2.06▼ | 2.02▼ | 1.96▼ | 4.64▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.009▲ | 0.013▲ | 0.011▲ | -0.034▼ | 0.465▲ |
| RSI | 48.602▼ | 45.415▼ | 42.276▼ | 40.969▼ | 35.358▼ |
| STOCH | 16.382▼ | 21.935 | 38.380 | 11.680▼ | 11.714▼ |
| WILL %R | -44.118 | -42.500 | -42.500 | -83.803▼ | -94.550▼ |
| CCI | 49.880 | 46.228 | 39.649 | -71.812 | -141.382▼ |
|
Wednesday, April 24, 2024 07:47 AM
Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal ; Study met primary efficacy endpoint of improvement in nasa ...
|
|
Wednesday, April 24, 2024 07:11 AM
Altamira Therapeutics (CYTO) shares surge as positive results from the NASAR trial of their Bentrio nasal spray for allergic rhinitis are published.
|
|
Tuesday, April 23, 2024 04:22 AM
Berkshire Hathaway, Inc. engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/04/24 | 1.57 | 1.57 | 1.40 | 1.495 | 2,949,402 |
| 23/04/24 | 1.40 | 1.58 | 1.38 | 1.58 | 110,808 |
| 22/04/24 | 1.39 | 1.52 | 1.38 | 1.40 | 107,242 |
| 19/04/24 | 1.50 | 1.50 | 1.405 | 1.414 | 46,743 |
| 18/04/24 | 1.46 | 1.5185 | 1.42 | 1.50 | 24,812 |
| 17/04/24 | 1.65 | 1.65 | 1.48 | 1.48 | 90,008 |
| 16/04/24 | 1.65 | 1.73 | 1.54 | 1.63 | 56,575 |
| 15/04/24 | 1.80 | 1.88 | 1.65 | 1.66 | 120,702 |
| 12/04/24 | 1.89 | 1.95 | 1.81 | 1.83 | 41,161 |
| 11/04/24 | 1.94 | 1.99 | 1.80 | 1.82 | 171,833 |
|
|
||||
|
|
||||
|
|